(LCI) MC $18 m- Ph 3 data next week .. there is over 10% short interest on this low floater so any good news will send this stock skyrocketing Pivotal Biosimilar Insulin Glargine Clinical Trial Top-line Results Anticipated in Current Quarter; BLA Filing Targeted for Middle of Calendar 2023